Coronavírus Página 8

DGS - COVID-19: Definição de Caso de COVID-19

Norma da Direção-Geral da SaúdeA Lei n.º 81/2009, de 21 de agosto instituiu um sistema de vigilância em saúde pública, que identifica situações de risco, recolhe, atualiza, analisa e divulga os dados relativos a doenças transmissíveis e outros...

NEJM - SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

The New England Journal of MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (Covid-19), which is most frequently mild yet can be severe and life-threatening. Virus-neutralizing monoclonal...

BMJ - Testing for SARS-CoV-2 antibodies

British Medical JournalAs the covid-19 pandemic has unfolded, interest has grown in antibody testing as a way to measure how far the infection has spread and to identify individuals who may be immune. Testing also has a clinical role, given...

ECDC - Key aspects regarding the introduction and prioritisation of COVID-19 vaccination in the EU/EEA and the UK

European Centre for Disease Prevention and ControlThis document provides an overview of the key aspects related to the initial phases following the introduction of one or more COVID-19 vaccines in the European Union and European Economic Area...

The Lancet - Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study

Little is known about the practice of ventilation management in patients with COVID-19. We aimed to describe the practice of ventilation management and to establish outcomes in invasively ventilated patients with COVID-19 in a single country...

JAMA - Best Practices for COVID-19–Positive or Exposed Mothers - Breastfeeding and Pumping Milk

JAMA NetworkDuring the coronavirus disease 2019 (COVID-19) pandemic, mothers who may be exposed or infected might be unsure about feeding their infant breast milk. Mothers, along with their family and health care professionals, should decide...

DGS - Estratégia Nacional de Testes para SARS-CoV-2

Direção-Geral da SaúdeDecorridos sete meses do reconhecimento da COVID-19 como pandemia, pela Organização Mundial da Saúde (OMS), importa fortalecer as linhas de intervenção, com base na evolução epidemiológica e no avanço do conhecimento...

ECDC - COVID-19 infection prevention and control measures for primary care, including general practitioner practices, dental clinics and pharmacy settings: first update

European Centre for Disease Prevention and ControlThis document provides guidance on infection prevention and control (IPC) measures to healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) in...

WHO - Handwashing can’t stop – millions of lives are at stake

World Health OrganizationGlobal Handwashing Day might seem a bit niche as international days go; you’d certainly be forgiven for never having marked it. But this year, today, it’s taken on a new urgency for millions of vulnerable children.

BMJ - Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

British Medical JournalWith few treatment options available to manage coronavirus disease 2019 (covid-19), the disease presents a unique set of challenges for healthcare providers globally. In addition to using non-drug interventions, health...

NEJM - Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

The New England Journal of MedicineThe efficacy of interleukin-6 receptor blockade in hospitalized patients with coronavirus disease 2019 (Covid-19) who are not receiving mechanical ventilation is unclear.

JAMA - Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial

JAMA NETWORK

What is the effect of tocilizumab, an anti–interleukin-6 receptor antibody, in patients with COVID-19 and moderate-to-severe pneumonia?

ECDC - Rapid Risk Assessment: Increased transmission of COVID-19 in the EU/EEA and the UK – thirteenth update